Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Clinical case of COVID‑19 in child with herpesvirus infection
https://doi.org/10.33667/2078-5631-2023-34-29-32
Abstract
According to the Ministry of Health of the Russian Federation (2022) 12–13% of cases of COVID‑19 were registered among children. Currently, COVID‑19 is considered as a systemic disease characterized by both respiratory and extrapulmonary symptoms, including dermatological manifestations. According to a number of foreign authors, the frequency of skin manifestations in COVID‑19 in children ranges from 0.2% to 20.4% of cases. The literature presents a few cases of exanthema in children, characterized by livedo, spotted-papular, urticar, papulo-vesicular elements, which determines the relevance of this problem. The clinical case of coronavirus infection in a child demonstrated by us against the background of dermatological manifestations is associated with the reactivation of EBV infection, which is quite rare in the practice of a pediatrician, thereby may cause certain difficulties in conducting differential diagnosis with a number of other diseases.
About the Authors
Yu. V. Maltseva
Orel State University n.a. I. S. Turgenev
Russian Federation
Russian Federation
Maltseva Yulia V., PhD Med, senior lecturer at Dept of Internal Medicine,
Orel.
L. A. Nadtocheeva
Scientific and Clinical Multidisciplinary Centre for Medical Care for Mothers and Children n.a. Z.I. Krugloy
Russian Federation
Russian Federation
Nadtocheeva Lyubov A., head of Second Infectious-Boxed Dept No. 2,
Orel.
L. Yu. Koroleva
Orel State University n.a. I. S. Turgenev
Russian Federation
Russian Federation
Koroleva Liliya Yu., senior lecturer at Dept of Internal Medicine,
Orel.
References
1. Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, et al. Tracking changes in SARS-CoV‑2 spike: Evidence that D614G increases infectivity of the COVID‑19virus. Cell. 2020; 182 (4): 812–827.
2. Safadi MA, Silva CA. O espectro desafiador e imprevisível da covid‑19 em crianças e adolescentes. Rev Paul Pediatr. 2021; 39: 2020192–2020192. Gonçalves LF, Gonzales AI, Patatt FS, Paiva KM, Haas P. Kawasaki and COVID‑19 disease in children: A systematic review. Rev Assoc Med Bras. 2020; (66): 136–142.
3. Chavda VP, Vuppu S, Mishra T, Kamaraj S, Patel AB, Sharma N, Chen ZS. Recent review of COVID‑19 management: Diagnosis, treatment and vaccination. Pharmacol Rep. 2022; 74 (6): 1120–1148.
4. Bogunovic D, Merad M. Children and SARS-CoV‑2. Cell Host Microbe. 2021; 29 (7): 1040–1042.
5. Alhumaid S., Al Mutair A., Al Alawi Z., Alshawi A. M., Alomran S. A., Almuhanna M.S., Almuslim A.A., Bu Shafia A.H., Alotaibi A.M., Ahmed G.Y. Coinfections with bacteria, fungi, and respiratory viruses in patients with SARS-CoV‑2: A systematic review and meta-analysis. Pathogens. 2021; 10 (7): 809.
6. Parri N, Lenge M, Buonsenso D. Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid‑19 in Pediatric Emergency Departments in Italy. N Engl J. Med. 2020; 383 (2): 187–190.
7. Yazdanpanah N, Rezaei N. Autoimmune complications of COVID‑19. J Med Virol. 2022; 94 (1): 54–62.
8. Shechter O, Sausen DG, Gallo ES, Dahari H, Borenstein R. Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments. International Journal of Molecular Sciences. 2022; 19; 23 (22): 14389.
Review
For citations:
Maltseva Yu.V., Nadtocheeva L.A., Koroleva L.Yu. Clinical case of COVID‑19 in child with herpesvirus infection. Medical alphabet. 2023;(34):29-32. (In Russ.) https://doi.org/10.33667/2078-5631-2023-34-29-32
Views:
320
Email this article 